• SENSEX 76,738.17
    585.31 (+0.77%)
  • BANKNIFTY 57,380.60
    208.60 (+0.36%)
  • Gland Pharma
    2,826.60 1,575.00(%)
  • Tata Technolog.
    830.10 890.15(%)
  • IFCI
    103.95 101.60(%)
  • HFCL
    231.40 257.00(%)
  • Lumino Inds
    122.00 119.00(%)
  • Jindal Worldwide
    57.06 47.55(%)
  • Netweb Technol.
    5,424.00 5,810.00(%)
  • Angel One
    308.20 360.20(%)
  • HBL Engineering
    723.85 1,121.95(%)
  • Multi Comm. Exc.
    3,257.00 3,479.80(%)
  • Adani Total Gas
    620.85 859.70(%)
  • Lenskart Solut.
    694.75 680.95(%)
  • Oberoi Realty
    1,932.25 1,985.00(%)
  • RBL Bank
    413.50 410.45(%)
  • Tejas Networks
    613.50 644.75(%)
  • Polycab India
    8,308.55 6,660.50(%)
  • Antelopus Selan
    986.05 357.00(%)
  • Nuvoco Vistas
    353.50 477.35(%)
  • One 97
    1,691.50 1,732.00(%)
  • Reliance Industries
    1,332.30 1,611.20(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Shukra Pharmaceuticals Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 4083.0
  • ISIN : INE551C01044
51.93 5 (10.99%)
  • As on 04 Sep 2026 (EOD)

  • Today’s Low

    47.10

  • Today’s High

    54.90

  • Open

    47.37

  • Perv Close

    46.79

  • 52W Low

    40.06

  • 52W High

    54.90

Key Indicators

  • P/E(TTM)

    63.41

  • Mar.Cap (₹Cr.)

    2,282.92

  • Div & Yield %

    0.02

  • Book Value(₹)

    2.18

  • Debt-Equity Ratio

    10.99

  • AGM Date

    03-Sep-2026

  • EPS

    0.82

  • P/E Ratio

    63.41

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    2,282.92

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    43.96

  • BV (₹)

    2.20

  • Sales( ₹ in Cr.)

    56.71

  • NP (in Cr.)

    22.05

  • NP Var(%)

    130.0

  • Div%

    1.0

  • CPS (₹)

    0.60

  • EPS (₹)

    0.50

  • Traded Value (₹ in Lakhs)

    2,286.00

  • 52 Week High

    54.90

  • 52 Week Low

    40.06

  • Price BSE

    52.0

  • Price NSE

    52.00

  • Market Capital( in Cr.)

    2,286.00

  • P/C Ratio

    89.70

  • P/E Ratio

    103.70

  • Price Vs.BV

    0.50

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 32.59 74.57 58.83 20.49 11.20 13.73
Excise Duty 0.00 0.00 0.00 0.00 0.00 1.89
Net Sales 32.59 74.57 58.83 20.49 11.20 11.84
Other Income 4.21 2.82 1.20 0.08 0.36 0.11
Stock Adjustments 3.63 -0.70 0.33 0.73 0.19 0.33
Total Income 40.43 76.69 60.36 21.30 11.75 12.28
EXPENDITURE :            
Raw Materials 11.75 43.78 45.65 11.08 2.96 3.33
Power and Fuel Cost 0.00 0.00 0.00 0.00 1.78 1.64
Employee Cost 5.47 5.02 4.41 4.57 3.75 4.34
Other Manufacturing Expenses 0.18 0.05 0.11 0.17 0.09 0.12
Selling and Administration Expenses 5.83 5.15 3.38 2.44 1.36 1.21
Miscellaneous Expenses 0.27 0.47 0.26 0.07 0.21 0.01
Employee Benefit Expenses 5.47 5.02 4.41 4.57 3.75 4.34
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 23.50 54.46 53.80 18.33 10.14 10.64
Operating Profit 16.93 22.22 6.56 2.97 1.60 1.65
Interest 0.59 0.29 0.28 0.29 0.03 0.00
Gross Profit 16.34 21.93 6.28 2.68 1.57 1.65
Depreciation 3.00 2.05 1.84 1.66 1.47 1.48
Profit Before Tax 13.34 19.88 4.44 1.02 0.10 0.17
Current Tax 3.62 1.36 0.01 0.21 -0.20 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.14 -0.02 0.03 0.06 0.11 0.14
Reported Net Profit 9.58 18.54 4.41 0.75 0.19 0.04
Extraordinary Items 0.00 0.00 0.00 0.00 -0.07 0.02
Adjusted Net Profit 9.58 18.54 4.41 0.75 0.26 0.02
Adjustment below Net Profit -32.84 -0.01 0.00 0.00 0.00 0.00
P & L Balance brought forward 37.57 19.10 14.78 14.03 13.85 9.65
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.07 0.08 0.00 0.00 0.00
P & L Balance carried down 14.30 37.57 19.11 14.78 14.03 9.69
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 1.00 10.00 5.00 5.00 0.00 0.00
Dividend Per Share(Rs) 0.01 1.00 0.50 0.50 0.00 0.00
Earnings Per Share-Unit Curr 0.22 16.93 11.26 4.79 1.20 0.23
Earnings Per Share(Adj)-Unit Curr 0.22 0.42 0.28 0.02 0.01 0.00
Book Value 1.44 52.65 64.63 104.43 99.63 98.43
Book Value(Adj)-Unit Curr 1.44 1.32 1.61 0.54 0.51 0.51

Shareholding Pattern

  • Promoter Group

    51.15%

  • Public Share Holding

    48.85%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 210,250,600 47.83 210,250,600 3
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 14,620,000 3.33 14,620,000 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 224,870,600 51.15 224,870,600 7
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 500,000 0.11 500,000 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 15,000 0.00 15,000 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 515,000 0.12 515,000 2
2] Non Institution
Bodies Corporate 693,841 0.16 693,831 41
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 168,360,852 38.30 168,360,852 130
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 10,936,361 2.49 10,936,361 21
Individuals holding nominal share capital up to Rs. 1 lakh 30,120,745 6.85 29,337,075 27,930
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 4,117,041 0.94 4,029,361 253
Sub Total 214,228,840 48.73 213,357,480 28,375
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 439,614,440 100.00 438,743,080 28,384

Company Background

Shukra Pharmaceuticals LtdPharmaceuticals - Indian - Formulations

  • Shukra Pharmaceuticals Ltd
  • BSE Code : 4083.0
  • ISIN : INE551C01044

  • Incorporation Year

    1993

  • Registered Office

    3 rd Floor Dev House
    Opp WIAA Office Judges Bungalo, Ahmedabad,
    Gujarat-380054

  • Telephone

    91-079-66522247/27498515

  • FAX

  • Chairman

    Dakshesh Shah

  • Managing Director

    Dakshesh Shah

  • Company Secretary

    Shivkant Dhakad

  • Auditor

    MAAK & Associates

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    Purva Sharegistry (I) Pvt Ltd
    9 ShivShakti Indl Es,
    J R Boricha Marg,Lower Parel
    Mumbai - Mumbai - 400 011

Shukra Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Shukra Pharma. 52.00 36.79 32.59 63.41 21.76
Abbott India 25,878.50 7,217.19 6,929.05 34.06 43.78
Astrazeneca Phar 6,946.95 2,304.07 2,275.58 102.39 27.86
Glaxosmi. Pharma 2,935.35 3,932.76 3,790.20 46.89 58.17
Novartis India 1,614.95 398.23 356.27 40.78 16.64
Cipla 1,389.00 20,102.60 18,979.95 36.50 13.88
Bliss GVS Pharma 636.90 773.53 729.81 59.14 12.51
Amrutanjan Healt 507.20 520.13 502.55 27.17 24.16
Fermenta Biotec. 502.80 474.15 450.25 23.47 18.77
Guj. Themis Bio. 425.00 152.47 150.80 113.64 27.21
Ambalal Sarabhai 43.88 19.52 3.94 81.26 6.77